Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-03-29 ±Ý 08:36
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 24°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Journal Briefing]
"AF ȯÀÚ Áß ¼ö¸é¹«È£ÈíÁõ ÈçÇØ"
ÇãÈñÀ± ±âÀÚ
2021-06-17 14:40
[Conference Report]
¡®°íÇ÷¾ÐÀü´Ü°è¡¯ºÎÅÍ Ç×°íÇ÷¾ÐÁ¦ ½á¾ßÇϳª?
ÀÌ»óµ· ±âÀÚ
2020-09-29 13:19
[Deep in Guideline]
2´Ü°è Áø´ÜÀ¸·Î Ä¡¸Å Á¾·ù±îÁö ÆÄ¾Ç °Á¶
ÀÓ¼¼Çü ±âÀÚ
2020-09-29 13:19
[Late Breaking Studies]
Ä¡¸Å¿¡ ´øÁö´Â µÎ °¡Áö Áú¹®
ÀÌ»óµ· ±âÀÚ
2020-09-29 13:19
[Sub Story]
Çѱ¹Çü Á¶Çöº´ °¡À̵å¶óÀÎ ³ª¿Ô´Ù
ÀÌ»óµ· ±âÀÚ
2020-09-29 13:18
¶óÀÎ
[Sub Story]
ÀÎÁö¿ä¹ý + Àú°µµ Ç׿ì¿ïÁ¦·Î Ä¡·á ½ÃÀÛ
ÀÓ¼¼Çü ±âÀÚ
2020-09-29 13:18
[Sub Story]
Á¤½Åº´Àû ¾ç»ó¿¡ µû¸¥ Ä¡·áÀü·« ±¸ºÐ
ÀÓ¼¼Çü ±âÀÚ
2020-09-29 13:17
[Cover Story]
Ä¿Á®°¡´Â Á¤½Å°Ç°Áúȯ À§Çè, ¼¼¹ÐÇØÁö´Â ¸ÂÃãÀü·«À¸·Î ¸Â¼±´Ù
ÀÓ¼¼Çü ±âÀÚ
2020-09-29 13:17
[Expert Opinion]
ÅëÁõ¼º ½ÅüÁõ»ó°ú ¿ì¿ïÁõÀÇ °ü¸®
THE MOST
2020-09-29 13:09
[Sub Story]
¿¬·Éº°¡¤À¯Çüº° °ü¸®Àü·« Á¦½Ã
ÀÓ¼¼Çü ±âÀÚ
2020-09-29 12:59
¶óÀÎ
[Drug Review]
¼¼ÀÎÆ®Á¸½º¿öÆ®,
¾ÈÀü¼º ³ôÀº °æÁõ~ÁßµîÁõ Ç׿ì¿ï Àü·«
ÀÓ¼¼Çü ±âÀÚ
2020-09-29 12:47
[Sub Story]
È¥À缺 ¾ç»ó±îÁö ´Ù·é Çѱ¹Çü ¾Ë°í¸®µë
ÀÓ¼¼Çü ±âÀÚ
2020-09-29 12:44
[Sub Story]
Ä¡·áÀúÇ×¼º¿¡ ÃÊÁ¡ µÐ ÃÖÃÊÀÇ ¾ç±Ø¼ºÀå¾Ö °¡À̵å¶óÀÎ
ÀÓ¼¼Çü ±âÀÚ
2020-09-29 12:41
[Sub Story]
¡®Ç׿ì¿ïÁ¦ + BZD°è Ç׺ҾÈÁ¦¡¯ ±â¹ÝÀü·« ±Ç°í
ÀÓ¼¼Çü ±âÀÚ
2020-09-29 12:26
[Sub Story]
¼Ò¾Æû¼Ò³â ADHD ¿¬·É¿¡ µû¸¥ Á¤È®ÇÑ Áø´Ü °Á¶
ÀÓ¼¼Çü ±âÀÚ
2020-09-29 12:19
¶óÀÎ
[Sub Story]
µ¿¹ÝÁúȯ Æ÷ÇÔÇÑ Á¤È®ÇÑ Áø´Ü °Á¶
ÀÓ¼¼Çü ±âÀÚ
2020-09-29 12:03
[Conference Report]
ATX + MPH·Î ºÎÁ·ÇÑ ADHD Ä¡·á¹ÝÀÀ º¸¿ÏÇÑ´Ù
ÀÓ¼¼Çü ±âÀÚ
2020-09-29 11:55
[Late Breaking Studies]
ATX + OROS-MPH »óÈ£º¸¿ÏÈ¿°ú ÀÔÁõ
ÀÓ¼¼Çü ±âÀÚ
2020-09-29 11:36
[Sub Story]
ºÒ¸éÀå¾Ö-¼ö¸é¹«È£ÈíÁõ Àû½Ã Áø´Ü¡¤Ä¡·á Áß¿ä
ÇãÈñÀ± ±âÀÚ
2020-09-29 11:25
[Expert Opinion]
½É±Ù°æ»öÁõÀ¸·Î ÀÎÇÑ ½ºÅÙÆ® ½Ã¼ú º´·Â °íÇ÷¾Ð ȯÀÚ¿¡¼
THE MOST
2020-09-29 11:15
-
1
2
-
¿©¹é
Sub
news
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù...
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â...
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?...
¿©¹é
¿©¹é
Back to Top